-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, B25v1l9hw0Moq236cqRuZuayfot7QiNTq8uolJoAesUm4KjJk1hnYzif1nIXqcrq tAKM4ekde/3eKQldhPurRw== 0001082554-08-000062.txt : 20080605 0001082554-08-000062.hdr.sgml : 20080605 20080605155309 ACCESSION NUMBER: 0001082554-08-000062 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080603 FILED AS OF DATE: 20080605 DATE AS OF CHANGE: 20080605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS CORP CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ferrari John Maxim CENTRAL INDEX KEY: 0001370940 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 08883016 BUSINESS ADDRESS: BUSINESS PHONE: 301-608-9292 MAIL ADDRESS: STREET 1: 1110 SPRING STREET CITY: SILVER SPRING STATE: MD ZIP: 20910 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2008-06-03 0 0001082554 UNITED THERAPEUTICS CORP UTHR 0001370940 Ferrari John Maxim 1110 SPRING STREET SILVER SPRING MD 20910 0 1 0 0 CFO Share Tracking Award 94.06 2008-06-03 2008-06-03 4 A 0 48375 0 A 2009-06-03 2018-06-03 Common Stock 48375 48375 D These non-dilutive share tracking awards vest in one-third increments on each of June 3, 2009, June 3, 2010, and June 3, 2011, and settle in cash only. These share tracking awards replace the same number of stock options previously granted to the reporting person on April 1, 2008, contingent upon shareholder approval of the company's 2008 Equity Incentive Plan. Such contingent options were canceled because shareholder approval was not obtained. /s/ Paul Mahon under Power of Attorney 2008-06-05 -----END PRIVACY-ENHANCED MESSAGE-----